|
|||||
|
New research from Gil Yosipovitch, M.D., Ph.D., professor of dermatology at Wake Forest Baptist Medical Center and a world-renowned itch expert, shows that how good scratching an itch feels is related to the itch’s location… View full post on Eczema / Psoriasis News From Medical . . . → Read More: All Itches Are Not Equal Around 7.5 million Americans, which is about 2.2% of the population, suffer from psoriaris, an autoimmune disease causing red, flaky skin… View full post on Eczema / Psoriasis News From Medical . . . → Read More: Psoriatic Arthritis – New Drug Offers Relief About 300 000 Swedes suffer from the difficult to treat disease, which manifests itself in scaly and often itchy patches on the skin. The reason is that cells divide without restraint as new blood vessels form in the deeper layers of the skin. An important component is the psoriasin protein (S100A7), which are abundant in psoriasis-affected skin but rarely in normal skin… View full post on Eczema / Psoriasis News From Medical . . . → Read More: A Plan To Effectively Treat Psoriasis About 300 000 Swedes suffer from the difficult to treat disease, which manifests itself in scaly and often itchy patches on the skin. The reason is that cells divide without restraint as new blood vessels form in the deeper layers of the skin. An important component is the psoriasin protein (S100A7), which are abundant in psoriasis-affected skin but rarely in normal skin… View full post on Eczema / Psoriasis News From Medical . . . → Read More: A Plan To Effectively Treat Psoriasis Collaborative research from Perelman School of Medicine at the University of Pennsylvania has shown that psoriasis patients have an increased risk of heart attack, stroke and cardiovascular death, especially if the psoriasis is moderate to severe. Now, Penn researchers have discovered the potential underlying mechanism by which the inflammatory skin disease impacts cardiovascular health… View full post on Eczema / Psoriasis News From Medical . . . → Read More: New Research May Provide Clues Into The Molecular Links Between Psoriasis And Heart Disease Among patients with moderate to severe psoriasis, treatment options that are most compatible with their personal and professional life appear to be most important, and treatment location appears matter more than probability and magnitude of treatment outcome, according to a report in the November issue of Archives of Dermatology, one of the JAMA/Archives journals… View full post on Eczema / Psoriasis News From Medical . . . → Read More: Importance Of Treatment Process And Outcomes Varies Among Patients With Psoriasis According to a study published in the November issue of Archives for Dermatology, one of the JAMA/Archives journals and written by scientists from the Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany, treatment options and locations for individuals suffering from moderate to severe psoriasis that are compatible with the patients’ personal and professional life… View full post on Eczema / Psoriasis News From Medical . . . → Read More: Psoriasis Patients – Variations In Importance Of Treatment Process And Outcomes Scientists have found that a strain of yeast implicated in inflammatory skin conditions, including eczema, can be killed by certain peptides and could potentially provide a new treatment for these debilitating skin conditions. This research is published in the Society for Applied Microbiology’s journal, Letters in Applied Microbiology… View full post on Eczema / Psoriasis News From Medical . . . → Read More: Yeast Offers Clue To A Cure For Eczema Scientists in Sweden have discovered certain peptides kill off the yeast Malassezia sympodialis which can trigger skin disorders such as atopic eczema, seborrhoeic eczema, and dandruff, without harming healthy skin cells. While further work is needed to clarify the underlying mechanisms, they hope their discovery will lead to a new treatment for these debilitating skin conditions… View full post on Eczema / Psoriasis News From Medical . . . → Read More: Eczema Yeast Can Be Killed Off, Raising Hope Of New Treatments At the annual European Academy of Dermatology and Venereology (EADV) Congress in Lisbon, Portugal, Novartis announced positive results from its three Phase II trials of AIN457 (secukinumab), a drug designed for the treatment of psoriasis. The results revealed quick and significant improvements of symptoms in patients with moderate-to-severe plaque psoriasis… View full post on Eczema / Psoriasis News From Medical . . . → Read More: 81% Of Proriasis Patients Benefited From AIN457 In Phase II Trial |
|||||
|
Copyright © 2012 ballochroy.com - All Rights Reserved
Powered by Yahoo! Answers Powered by Yahoo! Answers |
|||||
New comments